PakVita logo
Medicines A-Z
Back to Myo-Inositol Sachet

Myo-Inositol Sachet Side Effects in Pakistan

This guide covers Myo-Inositol Sachet (Myo-Inositol) for this formulation. Confirm the exact local label and individual prescription.

Compiled by the PakVita Editorial Team · AI-assisted drafting with editorial review · Sourced from DRAP, WHO, BNF · Last updated: · Review date on file:

A named review is not recorded for this page. Confirm medicine advice with your doctor or pharmacist.

The latest editorial changes have not received a new named clinical review.

Side Effects

Quick Answer

Reported effects of Myo-Inositol Sachet include Nausea (metli); Diarrhea. No serious adverse effects established at therapeutic doses; High doses (>12g/day) may cause significant GI disturbances require medical assessment. Lists do not establish how frequently an effect occurs.

Side Effects at a Glance

Reported effects

  • Nausea (metli)
  • Diarrhea
  • Stomach upset / bloating

Reactions needing medical advice

  • No serious adverse effects established at therapeutic doses
  • High doses (>12g/day) may cause significant GI disturbances

When to See a Doctor Immediately

  • No serious adverse effects established at therapeutic doses
  • High doses (>12g/day) may cause significant GI disturbances

Myo-Inositol Sachet side effects

Reported Effects (Nuksanat)

  • Nausea (metli)
  • Diarrhea
  • Stomach upset / bloating

Serious Effects and Warning Symptoms (Ahm alamat)

  • No serious adverse effects established at therapeutic doses
  • High doses (>12g/day) may cause significant GI disturbances

A list does not determine frequency or prove causation. Seek medical advice for persistent, worsening or unexpected symptoms.

Interactions (Dawaon ke sath reaction)

May complement metformin effects on insulin sensitivity (generally additive — inform doctor if taking metformin); minimal known drug interactions

Before Changing Treatment (Ilaj badalne se pehle)

  • Clinical benefits for ovulation, hair growth symptoms and weight are limited or uncertain.
  • Inositol is experimental as an infertility therapy in PCOS; discuss established treatment options with a specialist.
  • Do not use it as a substitute for diabetes treatment.
  • Check additional ingredients and discuss pregnancy or breastfeeding use with a clinician.

Related Information (Mazeed maloomat)

Full Myo-Inositol Sachet guide · Uses · Dosage · Side effects

Educational information only. This editorial correction does not constitute a new clinician review. Confirm the local product leaflet and prescription with a qualified healthcare professional.

Frequently Asked Questions

Myo-Inositol Sachet kis kaam aati hai?

Myo-Inositol Sachet contains Myo-Inositol. May be considered as a supplement in PCOS after discussing the limited evidence and personal preferences with a clinician. The diagnosis and exact product determine suitability.

Dose kaise confirm karein?

The 2023 international PCOS guideline does not recommend a particular inositol type, dose or combination because evidence quality is insufficient. Do not treat 2 g twice daily as a universally established regimen.

Bachon ke liye dose kya hai?

Not established for children — consult doctor

Pakistan mein price kitni hai?

A current price matched to the local strength and pack size has not been verified. Confirm the printed price, pack and expiry with a licensed pharmacy.

Nuksanat hon to kya karein?

Reported effects include Nausea (metli); Diarrhea; Stomach upset / bloating. Seek medical help for No serious adverse effects established at therapeutic doses; High doses (>12g/day) may cause significant GI disturbances. A symptom list does not predict how often an effect occurs.

Related medicines

Explore entries related to Myo-Inositol Sachet by ingredient, class and listed uses. These links are not recommendations to switch treatment.

Other diabetes medicines

Sibling medicines in the Diabetes Medicines class.

All in class →

Related by listed uses

Entries with overlapping pcos (polycystic ovary syndrome) tags; they may address different diagnoses.

PCOS (Polycystic Ovary Syndrome) hub →

Sources

  1. Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome — International PCOS Network / Journal of Clinical Endocrinology & Metabolism
  2. DRAP Registered Product Data (Public Registry) — Drug Regulatory Authority of Pakistan
  3. WHO Model List of Essential Medicines, 23rd ed. (2023) — World Health Organization
  4. British National Formulary (BNF) — BMJ Group & Pharmaceutical Press

Medical disclaimer

This page is for educational use only and does not replace professional medical advice. Always confirm diagnosis, dose, and interactions with a qualified doctor or pharmacist before starting or changing any medicine.